Anne Marie Taburet

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial

Yazdan Yazdanpanah, Catherine Fagard, Diane Descamps et al. · Clinical Infectious Diseases · 2009 · 237 citations

Medicine, Pharmacology, Pharmacotherapy +17

Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus*1, *2

Anne Marie Taburet · Clinical Pharmacology & Therapeutics · 2004 · 59 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation

Anne Marie Taburet, J Guibert, Marie-Dominique Kitzis et al. · Journal of Antimicrobial Chemotherapy · 1990 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia

Olivier Ségéral, Yoann Madec, Boroath Ban et al. · AIDS Research and Treatment · 2009 · 29 citations · Full text

Public Health, Infectious Diseases, Hiv Control +16

Disposition of Fleroxacin, a New Trifluoroquinolone, and Its Metabolites

E Singlas, A Leroy, Eric Sultan et al. · Clinical Pharmacokinetics · 1990 · 24 citations

Medicine, Pharmacokinetics, Pharmacology +10